WHO ICTRP trial

A clinical study with for objective to evaluate the safety, tolerability…

EUCTR2017-002068-42-BE · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2017-002068-42-BE
Public title A clinical study with for objective to evaluate the safety, tolerability, efficacy, compliance and acceptability of ADV7103 in patients with cystinuria
Scientific title Open label, multicentre study, evaluating the safety, tolerability, efficacy, compliance and the acceptability of alkalising treatments at long-term in patients with cystinuria
Primary sponsor Advicenne
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no
Countries France;Belgium
Conditions Cystinuria MedDRA version: 20.0 Level: PT Classification code 10011778 Term: Cystinuria System Organ Class: 10010331 - Congenital, familial and genetic disorders ;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal…
Interventions Product Name: ADV7103 Pharmaceutical Form: Prolonged-release granules INN or Proposed INN: potassium citrate monohydrate CAS Number: 6100-05-5 Current Sponsor code: ADV7103-CK Other descriptive name: potassium citrate Concentration unit: %…
Registration date Sep 10, 2018
Target size 97
Secondary IDs B14CS;NCT04137978;2017-002068-42-FR
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations